| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 76.66B | 77.12B | 76.76B | 74.87B | 77.10B | 79.66B |
| Gross Profit | 24.22B | 22.75B | 24.69B | 24.42B | 25.90B | 30.75B |
| EBITDA | 3.06B | 4.53B | 4.31B | 5.48B | 6.95B | 8.77B |
| Net Income | 527.00M | 1.30B | 637.00M | 1.09B | 2.40B | 4.24B |
Balance Sheet | ||||||
| Total Assets | 96.57B | 94.55B | 100.50B | 89.15B | 97.20B | 99.65B |
| Cash, Cash Equivalents and Short-Term Investments | 27.39B | 29.68B | 28.75B | 28.33B | 28.68B | 30.74B |
| Total Debt | 297.00M | 0.00 | 254.00M | 197.00M | 63.00M | 95.00M |
| Total Liabilities | 28.02B | 25.00B | 32.46B | 20.92B | 30.37B | 32.70B |
| Stockholders Equity | 68.54B | 69.54B | 68.03B | 68.22B | 66.83B | 66.96B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.71B | 2.31B | 1.41B | 940.00M | 3.52B |
| Operating Cash Flow | 0.00 | 5.34B | 4.34B | 4.29B | 3.22B | 6.42B |
| Investing Cash Flow | 0.00 | -3.72B | -3.63B | -2.75B | -2.30B | -2.11B |
| Financing Cash Flow | 0.00 | -928.00M | -927.00M | -1.43B | -2.52B | 852.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥1.19T | 36.08 | 7.76% | 1.67% | 3.12% | 21.97% | |
72 Outperform | ¥318.28B | 11.69 | 7.48% | 1.79% | 4.76% | 15.97% | |
70 Outperform | ¥945.94B | 16.87 | 5.45% | 1.30% | 4.46% | 21.50% | |
70 Outperform | ¥16.21B | 13.16 | ― | 3.04% | -3.59% | -29.46% | |
69 Neutral | ¥741.16B | 13.84 | 6.38% | 1.03% | 4.87% | 24.35% | |
62 Neutral | ¥27.85B | 27.18 | ― | 2.17% | 0.48% | 103.08% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |